Germany: SHS Capital and ING join investors in CAM Bioceramics

SHS Capital, the German healthcare specialist investor, along with ING Corporate Investments and other co-investors, is investing in CAM Bioceramics, a contract development and manufacturing organisation (CDMO) for innovative orthobiological calcium phosphate solutions. CAM Bioceramics, founded in 1985 as a spin-off from University Leiden Biomaterials Research Group, is focused on developing orthobiological calcium phosphates (CaPs)…

You must be a HMI Subscriber to view this content.

Subscribe Now »